“A Study of LY3475766 in Healthy Participants”
This three-part study will evaluate the safety and tolerability of LY3475766 when given to participants with high levels of blood fat called triglycerides and to healthy Japanese participants. It will also investigate how the body processes the study drug and the effect of the study drug on the body. Information about any side effects will be documented. This study will last up to 20 weeks for each participant.
Drug - LY3475766 - IV
Drug - LY3475766 - SC
Drug - Placebo - IV
Drug - Placebo - SC
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY3475766